1 RSV remains a significant burden primarily due ... Standard laboratory instrumentation and methodologies were used to analyze protein structure conformation. Size-exclusion chromatography ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, published in Nature ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

The surge in flu cases also comes amid concerns about high infection rates for other viruses including RSV, COVID-19 and the gastrointestinal bug norovirus. Still, health officials say flu cases ...

The inventors have created a reverse genetics system for RSV strain B1 of antigenic subgroup B encoding a replication-competent recombinant RSV that contains a codon-optimized G ORF and expresses ...